Categories Consumer, Earnings, Retail

Abercrombie & Fitch (ANF): Q4 2019 Earnings Snapshot

— Specialty apparel retailer Abercrombie & Fitch Co. (NYSE: ANF) reported adjusted earnings of $1.31 per share for the fourth quarter of 2019, vs. $1.23 per share expected.

— Net income dropped to $83.13 million or $1.29 per share from $96.94 million or $1.42 per share in the fourth quarter of 2018

Abercrombie & Fitch Comparable Sales Trend

— Net sales moved up 3% annually to $1.18 billion, vs. $1.17 billion expected; comparable store sales were up 1%, compared to 3% growth last year

— The board declared a quarterly cash dividend of $0.20 per share, payable on March 16, 2020, to stockholders of record on March 6, 2020

— Repurchased approximately 4.0 million shares of Abercrombie’s common stock during the quarter

— Expects net sales to be flat to up 2% in fiscal 2020, reflecting the estimated adverse impact of COVID-19 and unfavorable foreign exchange rates

— Expects full-year comparable sales to be down low-single digits; estimates gross profit to be down in the range of 50 basis points to 70 basis points year-over-year

— In the first quarter of 2020, net sales are expected to be down mid-single digits, reflecting the COVID-19 and foreign currency impacts

— First-quarter comparable sales are expected to be down mid-single digits; estimates gross profit to be down in the range of 100 basis points to 150 basis points

Get access to timely and accurate verbatim transcripts that are published within hours of the event.

Most Popular

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Walgreens Boots Alliance set to report earnings next week. Here’s what to expect

Walgreens Boots Alliance, Inc. (NASDAQ: WBA), the drug store chain that is expanding into a diversified healthcare provider, is on a restructuring drive aimed at better aligning the business with

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top